# name
Hepatocellular carcinoma: what are the differential costs compared to the general population?

# metadata.dc.description.abstract[].value
Hepatocellular carcinoma (HCC), which accounts for about 90% of all primary liver can-cer cases, is the fifth most common malignancy and the second leading cause of cancer-related mor-tality worldwide. This study aims to analyse the differential costs of HCC-related hospital admissionscompared to the general population in Spain (...)

# metadata.dc.relation.ispartof[].value
Journal of Medical Economics, 2025, vol. 28, num.1, p. 471-478

# metadata.dc.source[].value
Articles publicats en revistes (Economia)

# metadata.dc.title[].value
Hepatocellular carcinoma: what are the differential costs compared to the general population?